Jazz Pharmaceuticals (JAZZ) EBT Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-79.57% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-313.33% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Jazz Pharmaceuticals |
13.91 Bn |
12.06 Bn |
934.80 Mn |
372.50% |
| Date | Value |
|---|
| Mar 31, 2026 |
372.50% |
| Dec 31, 2025 |
56.49% |
| Sep 30, 2025 |
-95.50% |
| Jun 30, 2025 |
-633.29% |
| Mar 31, 2025 |
-6,753.93% |
| Dec 31, 2024 |
116.52% |
| Sep 30, 2024 |
101.78% |
| Jun 30, 2024 |
68.65% |
| Mar 31, 2024 |
-102.91% |
| Dec 31, 2023 |
118.10% |
| Sep 30, 2023 |
265.50% |
| Jun 30, 2023 |
289.19% |
| Mar 31, 2023 |
771.16% |
| Dec 31, 2022 |
-658.41% |
| Sep 30, 2022 |
11.10% |
| Jun 30, 2022 |
115.44% |
| Mar 31, 2022 |
-95.34% |
| Dec 31, 2021 |
-130.96% |
| Sep 30, 2021 |
-140.22% |
| Jun 30, 2021 |
-179.36% |
